AR062373A1 - Sales maleato, tosilato, fumarato y oxalato de la 5-(1(s)-amino-2-hidroxietil)-n-[(2,4-difluorofenil)-metil]-2-[8-metoxi-2-(trifluorometil)-5-quinolin]-4-oxazol carboxamida y procesos de preparacion para las mismas - Google Patents

Sales maleato, tosilato, fumarato y oxalato de la 5-(1(s)-amino-2-hidroxietil)-n-[(2,4-difluorofenil)-metil]-2-[8-metoxi-2-(trifluorometil)-5-quinolin]-4-oxazol carboxamida y procesos de preparacion para las mismas

Info

Publication number
AR062373A1
AR062373A1 ARP070103601A ARP070103601A AR062373A1 AR 062373 A1 AR062373 A1 AR 062373A1 AR P070103601 A ARP070103601 A AR P070103601A AR P070103601 A ARP070103601 A AR P070103601A AR 062373 A1 AR062373 A1 AR 062373A1
Authority
AR
Argentina
Prior art keywords
fumarate
maleate
oxalate
quinolin
hydroxyethyl
Prior art date
Application number
ARP070103601A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38895795&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR062373(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR062373A1 publication Critical patent/AR062373A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se revelan sales maleato, tosilato, fumarato y oxalato del compuesto 5-(1-(S)-amino-2-hidroxietil)-N-[(2,4-difluoro-fenil)-metil]-2-[8-metoxi-2-(trifluorometil)-5-quinolin]-4-oxazolcarbonamida. Procesos de preparacion de las formas salinas mencionadas. Reivindicacion 1: Una forma salina cristalina del compuesto (1) seleccionada de una sal cristalina maleato monohidrato, forma l, sal cristalina tosilato hidrato, forma l, forma salina cristalina fumarato, y forma salina cristalina oxalato.
ARP070103601A 2006-08-14 2007-08-14 Sales maleato, tosilato, fumarato y oxalato de la 5-(1(s)-amino-2-hidroxietil)-n-[(2,4-difluorofenil)-metil]-2-[8-metoxi-2-(trifluorometil)-5-quinolin]-4-oxazol carboxamida y procesos de preparacion para las mismas AR062373A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83766106P 2006-08-14 2006-08-14

Publications (1)

Publication Number Publication Date
AR062373A1 true AR062373A1 (es) 2008-11-05

Family

ID=38895795

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103601A AR062373A1 (es) 2006-08-14 2007-08-14 Sales maleato, tosilato, fumarato y oxalato de la 5-(1(s)-amino-2-hidroxietil)-n-[(2,4-difluorofenil)-metil]-2-[8-metoxi-2-(trifluorometil)-5-quinolin]-4-oxazol carboxamida y procesos de preparacion para las mismas

Country Status (11)

Country Link
US (1) US7956189B2 (es)
EP (1) EP2069337A1 (es)
JP (3) JP2010500406A (es)
CN (1) CN101522671A (es)
AR (1) AR062373A1 (es)
CA (1) CA2660703A1 (es)
CL (1) CL2007002366A1 (es)
MX (1) MX2009001770A (es)
PE (1) PE20080424A1 (es)
TW (1) TW200819446A (es)
WO (1) WO2008021271A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1888548B1 (en) 2005-05-26 2012-08-22 Neuron Systems, Inc Quinoline derivative for the treatment of retinal diseases
WO2014012859A1 (en) * 2012-07-19 2014-01-23 Boehringer Ingelheim International Gmbh Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as medicament and the preparation thereof
MX2020003425A (es) 2017-10-10 2020-07-29 Aldeyra Therapeutics Inc Tratamiento de trastornos inflamatorios.
US12006298B2 (en) 2018-08-06 2024-06-11 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7511062B2 (en) * 2004-05-18 2009-03-31 Schering Corporation Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors

Also Published As

Publication number Publication date
US7956189B2 (en) 2011-06-07
CN101522671A (zh) 2009-09-02
MX2009001770A (es) 2009-02-25
PE20080424A1 (es) 2008-04-28
TW200819446A (en) 2008-05-01
JP2010500406A (ja) 2010-01-07
US20080108818A1 (en) 2008-05-08
EP2069337A1 (en) 2009-06-17
JP2013032394A (ja) 2013-02-14
JP2012176989A (ja) 2012-09-13
CA2660703A1 (en) 2008-02-21
WO2008021271A1 (en) 2008-02-21
CL2007002366A1 (es) 2008-03-14

Similar Documents

Publication Publication Date Title
AR109423A2 (es) Sal moduladora de la vía hedgehog
CL2015000332A1 (es) Forma cristalina a y racemato cristalino de 1-(5'-(5-(3,5-dicloro-4-fluorofenil)-5-(trifluorometil)-4,5-dihidroisoxazol-3-il)-3'h-espiro[azetidin-3,1'-isobenzofuran]-1-il)-2-(metilsulfonil)etanona; procedimiento de preparacion de la forma cristalina a; composicion que la comprende; y su uso para el tratamiento de una infeccion o infestacion parasitaria.
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
MX2008001793A (es) Derivados de bisamida biciclica y uso de los mismos como insecticidas.
LTC2076501I2 (lt) 3-[5-(2-fluorfenil)-[1,2,4]oksadiazol-3-il]benzenkarboksirūgšties kristalinės formos
UA110963C2 (uk) Гербіцидна композиція, що містить флазасульфурон і інгібітор протопорфіриногеноксидази
TW200716593A (en) Novel insecticides
JO3021B1 (ar) احادي هيدرات 4-[ 4-{[4- كلورو - 3- (ثلاثي فلورو ميثيل) فينيل ] كربامويل} امينو] -3- فلورو فينوكسي] -n- ميثيل بيريدين -2- كربوكساميد
RS53056B (en) PHARMACEUTICAL PREPARATION CONTAINING (1S) -1,5-ANHYDRO-1- [5- (4-ETHOXYBENZYL) -2-METHOXY-4-METHYLPHENYL] -1-THI-D-GLUCITOL AND METFORMIN AND ITS USE IN THE TREATMENT OF DIABETES
EA201000702A1 (ru) Некоторые производные 2-пиразинона и их применение в качестве ингибиторов нейтрофильной эластазы
TW200626069A (en) Novel insecticides
PE20110062A1 (es) N-(3-(3,5-dimetoxifenetil)-1h-pirazol-5-il)-4-(3,4-dimetilpiperazin-1-il)benzamida y sales del mismo
UY30090A1 (es) Insecticidas novedosos
EA200600381A1 (ru) Метансульфонат этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1н-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и его применение в качестве лекарственного средства
EA201691242A1 (ru) Фармацевтические композиции, содержащие azd9291
FI2785349T4 (fi) Syövän yhdistelmähoito
AR062373A1 (es) Sales maleato, tosilato, fumarato y oxalato de la 5-(1(s)-amino-2-hidroxietil)-n-[(2,4-difluorofenil)-metil]-2-[8-metoxi-2-(trifluorometil)-5-quinolin]-4-oxazol carboxamida y procesos de preparacion para las mismas
TW200637841A (en) Novel insecticides
EG25049A (en) 1-(1,2-diphenyl-ethyl)-3-(2-hydroxyethyl)-thioureacompounds for combating animal pests.
RS52988B (en) Trans-4 - [[(5S) -5 - [[[3,5-bis (trifluoromethyl) phenyl] methyl] (2-methyl-2H-tetrazol-5-yl) amino] -2,3,4,5 -TETRAHYDRO-7,9-DIMETHYL-1H-1-BENZAZEPIN-1-yl] METHYL] -CYCLOHEXANECARBOXYLIC ACID
ATE468333T1 (de) N-cyanoalkylanthranilamide als insektizide
PE20090166A1 (es) Sales de adicion de acido, hidratos y polimorfos de la etil-amida del acido 5-(2,4-dihidroxi-5-isopropil-fenil)-4-(4-morfolin-4-il-metil-fenil)-isoxazol-3-carboxilico, y formulaciones que comprenden estas formas
TW200626532A (en) Novel insecticides
TW200628432A (en) Novel insecticides
CL2013000797A1 (es) Proceso de preparacion de (2r,3r)-3-{4-(s-(ciclo)alquil-sulfonimidoil)fenil}amino}-5-(trifluorometil)pirimidin-4-il}oxi}butan-2-2ol inhibidores; y los compuestos intermediarios considerados.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal